Brought to you by 
Light Sciences brings in $30mm with Series B placement
10 Jul 2007
Executive Summary
In what the company is calling its mezzanine round, Light Sciences Oncology (light-activated drug therapy for cancer) raised $30mm in a private placement of its Series B preferred shares to undisclosed investors.
Deal Industry
- Biotechnology
- Medical Devices
- Pharmaceuticals
Deal Status
- Final
Deal Type
-
Financing
- Venture Financing
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Light Sciences brings in $30mm with Series B placement
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice